| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 06:44:07 UTC |
|---|
| Update Date | 2021-09-26 23:00:56 UTC |
|---|
| HMDB ID | HMDB0249842 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one |
|---|
| Description | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one, also known as CFM 2, belongs to the class of organic compounds known as benzodiazepines. These are organic compounds containing a benzene ring fused to either isomers of diazepine(unsaturated seven-member heterocycle with two nitrogen atoms replacing two carbon atoms). Based on a literature review very few articles have been published on 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one. This compound has been identified in human blood as reported by (PMID: 31557052 ). 1-(4-aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | COC1=C(OC)C=C2C(CC(=O)NN=C2C2=CC=C(N)C=C2)=C1 InChI=1S/C17H17N3O3/c1-22-14-7-11-8-16(21)19-20-17(13(11)9-15(14)23-2)10-3-5-12(18)6-4-10/h3-7,9H,8,18H2,1-2H3,(H,19,21) |
|---|
| Synonyms | | Value | Source |
|---|
| 1-(4'-Aminophenyl)--3,5-dihydro-7,8-dimethoxy-4H-2,3-benzodiazepin-4-one | HMDB | | CFM 2 | HMDB |
|
|---|
| Chemical Formula | C17H17N3O3 |
|---|
| Average Molecular Weight | 311.341 |
|---|
| Monoisotopic Molecular Weight | 311.126991419 |
|---|
| IUPAC Name | 1-(4-aminophenyl)-7,8-dimethoxy-4,5-dihydro-3H-2,3-benzodiazepin-4-one |
|---|
| Traditional Name | 1-(4-aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | COC1=C(OC)C=C2C(CC(=O)NN=C2C2=CC=C(N)C=C2)=C1 |
|---|
| InChI Identifier | InChI=1S/C17H17N3O3/c1-22-14-7-11-8-16(21)19-20-17(13(11)9-15(14)23-2)10-3-5-12(18)6-4-10/h3-7,9H,8,18H2,1-2H3,(H,19,21) |
|---|
| InChI Key | MJKADKZSYQWGLL-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as benzodiazepines. These are organic compounds containing a benzene ring fused to either isomers of diazepine(unsaturated seven-member heterocycle with two nitrogen atoms replacing two carbon atoms). |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzodiazepines |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Benzodiazepines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Benzodiazepine
- Anisole
- Aniline or substituted anilines
- Alkyl aryl ether
- Monocyclic benzene moiety
- Benzenoid
- Amino acid or derivatives
- Carboxylic acid derivative
- Ether
- Azacycle
- Organonitrogen compound
- Amine
- Organic nitrogen compound
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organooxygen compound
- Primary amine
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross Sections| Predictor | Adduct Type | CCS Value (Å2) | Reference |
|---|
| DeepCCS | [M+H]+ | 176.066 | 30932474 | | DeepCCS | [M-H]- | 173.708 | 30932474 | | DeepCCS | [M-2H]- | 206.976 | 30932474 | | DeepCCS | [M+Na]+ | 182.203 | 30932474 |
Predicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 10.9174 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.01 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1606.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 231.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 141.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 170.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 57.4 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 302.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 358.5 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 115.8 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 946.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 338.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1007.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 293.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 296.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 304.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 253.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 21.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,1TMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N[Si](C)(C)C)C=C1)=NNC(=O)C2 | 3302.6 | Semi standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,1TMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N[Si](C)(C)C)C=C1)=NNC(=O)C2 | 3059.2 | Standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,1TMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N[Si](C)(C)C)C=C1)=NNC(=O)C2 | 5275.4 | Standard polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,1TMS,isomer #2 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N)C=C1)=NN([Si](C)(C)C)C(=O)C2 | 3072.7 | Semi standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,1TMS,isomer #2 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N)C=C1)=NN([Si](C)(C)C)C(=O)C2 | 2951.7 | Standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,1TMS,isomer #2 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N)C=C1)=NN([Si](C)(C)C)C(=O)C2 | 4912.6 | Standard polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,2TMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C1)=NNC(=O)C2 | 3225.1 | Semi standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,2TMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C1)=NNC(=O)C2 | 3064.6 | Standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,2TMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C1)=NNC(=O)C2 | 5097.1 | Standard polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,2TMS,isomer #2 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N[Si](C)(C)C)C=C1)=NN([Si](C)(C)C)C(=O)C2 | 3155.6 | Semi standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,2TMS,isomer #2 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N[Si](C)(C)C)C=C1)=NN([Si](C)(C)C)C(=O)C2 | 3097.4 | Standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,2TMS,isomer #2 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N[Si](C)(C)C)C=C1)=NN([Si](C)(C)C)C(=O)C2 | 4799.7 | Standard polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,3TMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C1)=NN([Si](C)(C)C)C(=O)C2 | 3032.7 | Semi standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,3TMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C1)=NN([Si](C)(C)C)C(=O)C2 | 3103.1 | Standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,3TMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C1)=NN([Si](C)(C)C)C(=O)C2 | 4571.3 | Standard polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,1TBDMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C1)=NNC(=O)C2 | 3523.6 | Semi standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,1TBDMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C1)=NNC(=O)C2 | 3254.5 | Standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,1TBDMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C1)=NNC(=O)C2 | 5257.9 | Standard polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,1TBDMS,isomer #2 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N)C=C1)=NN([Si](C)(C)C(C)(C)C)C(=O)C2 | 3291.0 | Semi standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,1TBDMS,isomer #2 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N)C=C1)=NN([Si](C)(C)C(C)(C)C)C(=O)C2 | 3136.6 | Standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,1TBDMS,isomer #2 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N)C=C1)=NN([Si](C)(C)C(C)(C)C)C(=O)C2 | 4899.2 | Standard polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,2TBDMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1)=NNC(=O)C2 | 3622.3 | Semi standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,2TBDMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1)=NNC(=O)C2 | 3465.8 | Standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,2TBDMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1)=NNC(=O)C2 | 5089.9 | Standard polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,2TBDMS,isomer #2 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C1)=NN([Si](C)(C)C(C)(C)C)C(=O)C2 | 3596.1 | Semi standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,2TBDMS,isomer #2 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C1)=NN([Si](C)(C)C(C)(C)C)C(=O)C2 | 3474.2 | Standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,2TBDMS,isomer #2 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C1)=NN([Si](C)(C)C(C)(C)C)C(=O)C2 | 4723.2 | Standard polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,3TBDMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1)=NN([Si](C)(C)C(C)(C)C)C(=O)C2 | 3652.4 | Semi standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,3TBDMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1)=NN([Si](C)(C)C(C)(C)C)C(=O)C2 | 3664.3 | Standard non polar | 33892256 | | 1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one,3TBDMS,isomer #1 | COC1=CC2=C(C=C1OC)C(C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1)=NN([Si](C)(C)C(C)(C)C)C(=O)C2 | 4539.0 | Standard polar | 33892256 |
|
|---|